|
Post by dayanand33 on Oct 20, 2014 16:30:41 GMT
|
|
|
Post by JHam on Oct 20, 2014 17:17:39 GMT
Yeah these are really good results. This one was off our radar because it isn't a publicly traded company. BCLI's interim Phase IIa results were also very good. The ALSFRS-R score of p=0.035 is the only thing we really know of their interim data. Other than that 63% of the 10 patients (out of 14) whose data was analyzed showed halting or signs of improvement. And then you have to take into account that 29% of BCLI's patients showed stabilization in the 3 months prior to treatment, so I believe that waters down the data numbers a bit. We'll just have to sit and wait until BCLI releases top-line data. This definitely good data though and something to keep an eye on if you are a BCLI/CUR investor. Very good news for ALS sufferers.
|
|
|
Post by JHam on Oct 22, 2014 10:01:11 GMT
Up over 9% in after hours trading. Back over $4.05...we'll see if it holds over to pre-market.
|
|
|
Post by tradeup on Oct 24, 2014 13:21:48 GMT
Averaged down to $3.62. Top-line results are overdue.
|
|
|
Post by dayanand33 on Nov 3, 2014 16:10:27 GMT
ouch! what happened today. Down 6% with no good or bad news.
|
|
|
Post by JHam on Nov 3, 2014 17:27:01 GMT
ouch! what happened today. Down 6% with no good or bad news. It's been heading this way the past few days. I think it has to do with the lack of news (still waiting trial data) and the natural adjustment to being r/s and up-listed. If I had more cash freed up I would probably be buying more at these levels.
|
|
|
Post by JHam on Nov 14, 2014 16:51:27 GMT
Just sold a third of my shares as well at a 2% loss and put it into NRIFF. Not feeling as confident on the impact that the data will have, but still have enough in the event that it does. I will start to add again probably as we get into next year.
|
|
|
Post by jckrdu on Nov 14, 2014 18:58:37 GMT
Just sold a third of my shares as well at a 2% loss and put it into NRIFF. Not feeling as confident on the impact that the data will have, but still have enough in the event that it does. I will start to add again probably as we get into next year. I just bought your shares. Playing it for a quick trade on results.
|
|
|
Post by lcd on Nov 14, 2014 19:31:44 GMT
jckrdu,
I think you made a good purchase at these prices. I would consider buying more but I stuck all my play money in STEM earlier this week. I think this stock is so starved for news that if they do release top level results in the next few weeks (per the conference call Q&A), then we will see a spike that hopefully pushes the pps back over $4. After that event, it might be 3-4 months before any additional news comes out so I will probably look to lighten my holdings on any price spikes too.
|
|
|
Post by jckrdu on Nov 19, 2014 16:29:06 GMT
Just sold some BCLI to start a position in ONCS. Both have some near-term catalysts.
|
|
|
Post by lcd on Nov 20, 2014 14:49:13 GMT
The chart for this is horrible and I don't know where it will eventually find support. I am way in the red but haven't sold any because I like it for the long term but I sure wish I hadn't jumped in when I did at over $4.
|
|
|
Post by dayanand33 on Nov 20, 2014 15:38:36 GMT
The chart for this is horrible and I don't know where it will eventually find support. I am way in the red but haven't sold any because I like it for the long term but I sure wish I hadn't jumped in when I did at over $4. It holds great promise. Such a pity that it's falling for no apparent reason. That's one of the reasons why I am so disillusioned with buy and hold. It hardly works with penny stocks.
|
|
|
Post by JHam on Nov 21, 2014 2:48:25 GMT
The chart for this is horrible and I don't know where it will eventually find support. I am way in the red but haven't sold any because I like it for the long term but I sure wish I hadn't jumped in when I did at over $4. It holds great promise. Such a pity that it's falling for no apparent reason. That's one of the reasons why I am so disillusioned with buy and hold. It hardly works with penny stocks. Wise words and I agree. With penny stocks and really any stocks that are still a long way away from bringing in revenue. I figured there would be some volatility after the r/s and up-list. Somewhere I wouldn't be surprised if it headed down to $3 and even a tad under $3. I think the biggest issue is that most anticipated that the data publication would come out shortly after the r/s and up-list. We are a few months past that now and it still hasn't happened. Then we also need to consider that Fiorino said on the last call that they expected the data to be in alignment with the interim data that was already announced. Which is good, because it was good data, but likely not going to cause the pop we all hoped for since there is nothing new there. Couple those item with what I think is the biggest issue, imminent dilution, and you have the reason why it is headed lower. I shaved off 1/3 of my position the other day at a 4% loss and put it into NRIFF (because I think that is the better short term play for now). That said though, I think there are two potential positives besides the data publication that could cause some short term pps relief. 1. If they file an IND for Parkinson's (or MS) in the next few months, and 2. If they secure a chunk of non-dilutive funding in the form of ice bucket challenge money. I think both of these items are very possible and would create a very favorable market reaction. If BCLI receives ice bucket challenge money they'd likely PR the hell out of it. It would show the millions of donators where their money went and bring in direct interest to the company at a time where supporting ALS is pretty popular.
|
|
|
Post by JHam on Dec 1, 2014 15:05:24 GMT
Things are getting ugly here lately with BCLI. I hope that data comes out soon and that it is very positive. I also hope that they don't dilute immediately after at these levels.
|
|
|
Post by dayanand33 on Dec 1, 2014 15:11:24 GMT
Things are getting ugly here lately with BCLI. I hope that data comes out soon and that it is very positive. I also hope that they don't dilute immediately after at these levels. So hard to watch this bleed for no reason. Short interest is less than 10% of average daily volume. www.nasdaq.com/symbol/bcli/short-interest It is much better than other stocks like CUR, ATHX or Ocata. Not to mention the volume is anemic as the pps diving down. I don't want to sell it because I cannot find reasons to do so.
|
|
|
Post by JHam on Dec 1, 2014 15:17:59 GMT
Things are getting ugly here lately with BCLI. I hope that data comes out soon and that it is very positive. I also hope that they don't dilute immediately after at these levels. So hard to watch this bleed for no reason. Short interest is less than 10% of average daily volume. www.nasdaq.com/symbol/bcli/short-interest It is much better than other stocks like CUR, ATHX or Ocata. Not to mention the volume is anemic as the pps diving down. I don't want to sell it because I cannot find reasons to do so. Your post pretty much sums up exactly how I feel.
|
|
|
Post by RLC on Dec 1, 2014 16:17:55 GMT
Things are getting ugly here lately with BCLI. I hope that data comes out soon and that it is very positive. I also hope that they don't dilute immediately after at these levels. This has been the weak spot in my portfolio. I got in at $3.54 thinking it was a very low-risk entry point. How wrong I was...
|
|
|
Post by JHam on Dec 16, 2014 14:35:26 GMT
Just added a small chunk at $3.08. Data should be any day now.
|
|
|
Post by dayanand33 on Dec 16, 2014 17:15:33 GMT
Just added a small chunk at $3.08. Data should be any day now. I think the CEO said that he may wait to reveal the data in a conference sometime in Jan or early next year. But this does seem to be a good entry point considering that it's beaten down for no reason. I sold 2/3 of my position at $3.00 and put it into CUR. Pity it is going up now. Never mind that's life. Happy for the ones who held thru the bottom
|
|
|
Post by lcd on Dec 18, 2014 16:05:46 GMT
Not that I know much about reading charts but finally this one is starting to turn around. I hope it continues but I still can't explain the cause of the drop to even these levels ($3.38 at the moment).
|
|